Smart Olfaction App for Smoking Addiction
(SOARR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people quit smoking by combining a smartphone app with a scent-based system to reduce cigarette cravings. Participants will use either the Smart Olfaction App alone or the app with the scent system to determine which is more effective. It suits individuals who smoke at least five cigarettes a day, are motivated to quit, and own an Apple or Android smartphone. As an Early Phase 1 trial, this research aims to understand how the treatment works in people, offering participants the opportunity to be among the first to try this innovative approach.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this olfactory stimulation delivery system is safe for smoking cessation?
Research has shown that smoking cessation apps, like the Smart-T app, can help people quit smoking. In studies, users of Smart-T were almost twice as likely to quit compared to those using another app called QuitGuide. This suggests that Smart-T effectively aids users in stopping smoking.
Regarding safety, this trial is in its earliest phase, meaning the app is just beginning safety testing in people. Although specific safety data for the Smart Olfaction App is not yet available, smoking cessation apps generally are safe to use. They do not involve medication, so they tend to have fewer side effects.
In summary, while specific safety data for the Smart Olfaction App is not yet available, similar apps have been safe for users and effective in helping people quit smoking.12345Why are researchers excited about this trial?
Researchers are excited about the Smart Olfaction App for smoking addiction because it offers a novel approach to tackling nicotine dependence. Unlike traditional methods such as nicotine replacement therapy (NRT) or medications like varenicline, this app uses smell to influence cravings and smoking behavior. The app's unique mechanism involves olfactory stimulation, which could potentially alter smoking habits by using specific scents to reduce the urge to smoke. Another exciting aspect is its integration with the Inspire device, further enhancing its effectiveness by combining digital health with sensory cues. This innovative approach could pave the way for more personalized and effective smoking cessation strategies.
What evidence suggests that this trial's treatments could be effective for smoking addiction?
Research has shown that smartphone apps can help people quit smoking. One study found that the Smart-T app, which participants in this trial may use, worked better for adults with lower income levels compared to another popular app. A review of several studies demonstrated that mobile apps can help more smokers quit. Although the Stop-tabac app did not increase quitting rates, it encouraged more people to use nicotine medications. These findings suggest that using a smartphone app like Smart-T, along with scent-based methods, could reduce cigarette cravings and support efforts to quit smoking. Participants in this trial may also use the Inspire device in different phases to further aid smoking cessation.14678
Who Is on the Research Team?
Lorra Garey, Ph.D.
Principal Investigator
University of Houston
Michael Businelle, Ph.D.
Principal Investigator
University of Oklahoma Health Sciences
Michael Sayette, Ph.D.
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for individuals trying to quit smoking and are comfortable using smartphone apps. Participants should be willing to use the Smart-T Smoking Cessation App and may also be asked to use a device called Inspire that delivers olfactory stimulation. People who don't want to engage with technology or have conditions that interfere with app/device usage cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase I: Treatment
Participants engage in a self-guided quit attempt using the OSDS for 14 days with crossover randomization design
Phase II: Treatment
Participants are randomized to Smart-T with or without OSDS and use a nicotine patch for smoking cessation
Follow-up
Participants are monitored for smoking abstinence and device acceptability
What Are the Treatments Tested in This Trial?
Interventions
- Smart Olfaction App
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Houston
Lead Sponsor
University of Pittsburgh
Collaborator
University of Oklahoma
Collaborator
Brown University
Collaborator